Contact Us

By telephone
During office hours
(Monday-Friday 08:30-17:00)
+44 (0)1234 400 400

Outside office hours
(Campus Watch)
+44 (0)1582 74 39 89

By email
admission@beds.ac.uk (admissions)
international@beds.ac.uk (international)
sid@beds.ac.uk (student support)
help@beds.ac.uk (registration)

By post
University of Bedfordshire
Park Square
Luton
Bedfordshire
UK, LU1 3JU

Sarah Wadd

Director of the Substance Misuse and Ageing Research Team (SMART) at the Tilda Goldberg Centre

Following her PhD in Virology at the Medical Research Council’s Virology Unit in Glasgow, Sarah worked for five years for the NHS in Scotland as an epidemiologist specialising in infections associated with injecting drug use.  One of the projects that she led identified high risk injecting behaviour amongst drug users who lived in hostels for the homeless prompting Greater Glasgow Health Board to introduce a needle exchange service in Glasgow hostels. 

She was also a member of a multidisciplinary outbreak team including specialists from the Centre for Disease Control in Atlanta, to investigate an outbreak of unexplained severe illness (87% mortality) in IDUs in Scotland, England and Ireland. 

Laboratory investigations suggested that Clostridium novyii was the causative agent and a case-control study found that injecting drugs into muscle rather than a vein was a risk factor.  As a result of this study, health promotion literature now advises injecting drug users not to inject into muscle or skin. 

Sarah started work at the Tilda Goldberg Centre in April 2010 and identified substance misuse and ageing as an issue which is significantly under-researched but is likely to become of increasing importance and prominence in the future.  She has recently completed a study exploring the experiences of older people with alcohol problems and investigating what strategies and approaches are likely to be most successful in treating them.  The findings were the subject of an article in the Daily Telegraph. 

Sarah has also recently given presentations on alcohol misuse amongst older people at the Northern Ireland Parliament and the Society for Study of Addiction Annual Conference.  She has been invited to present her work at the 2012 New Directions in the Study of Alcohol Conference and has written an article on alcohol and ageing for the British Society of Gerontology which was published in the Society’s newsletter in July. 

Sarah is organising a one day conference on alcohol and ageing at King’s College London in July 2012, is in the process of writing a number of articles for publication in peer-reviewed journals and is developing a number of grant proposals.  She will shortly be starting a project with colleagues at the Brunel Institute of Ageing Studies to examine alcohol-related elder abuse.

Sarah also contributes to the work of the Centre which aims to widen the evidence base in relation to substance misuse and social work.  She has interviewed staff and managers of a service which plays a central role in responding to the needs of children affected by parental substance misuse in the London Borough of Islington to identify the core components, aims, outcomes and theories underpinning the service and prepared a report describing the findings.  Sarah has worked with Professor Forrester to prepare reports for the Welsh Assembly Government on the potential benefits of using Social Behaviour Network Therapy and Case Management for substance misuse in social work practice and co-authored a book chapter on substance misuse in social work practice with Dr Galvani.

Academic Qualifications

  • Masters Public Health - University of Glasgow, 2001-2003
  • PhD Virology - University of Glasgow, 1995-2000
  • BSc (Hons) Biochemistry 2(i) - University of North London, 1992-1995

Publications

  • Wadd S, Lapworth K, Sullivan M, Forrester D, Galvani S.  Working with Older Drinkers.  Tilda Goldberg Centre for Social Work and Social Care. 2011.
  • Galvani S, Wadd S.  Drug and Alcohol Practice in Social Work with Adults in M. Davis (Ed.). Basingstoke, Palgrave MacMillan.  In press.
  • Wadd S, Galvani S, Glynn G.  Report on the Camden Alcoholic Support Association Family Service Model Evaluation.  Tilda Goldberg Centre for Social Work and Social Care. 2010
  • Palmateer N, Anderson N, Wadd S, Hutchinson S, Taylor A, Goldberg D. Exploring associations between perceived HCV status and injecting risk behaviours among recent initiates to injecting drug use in Glasgow. Subst Use Misuse.2008;43(3-4):375-88.
  • Wadd S, Taylor A, Hutchinson SJ, Ahmed S, Goldberg D. High risk injecting behaviour in hostel accommodation for the homeless in Glasgow 2001-2: a study combining quantitative and qualitative methodology. Journal of Substance Use. 2006; 11(5): 333-341.
  • Roy KM, Hutchinson SJ, Wadd S, Taylor A, Cameron SO, Burns S, Molyneaux P, McIntyre PG, Goldberg DJ. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them. Epidemiol Infect. 2007 Apr;135(3):433-42. Epub 2006 Aug 8.
  • Hutchinson SJ, Roy KM, Wadd S, Bird SM, Taylor A, Anderson E, Shaw L, Codere G, Goldberg DJ. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges. Scott Med J. 2006 May;51(2):8-15. Review.
  • Judd A, Hutchinson S, Wadd S, Hickman M, Taylor A, Jones S, Parry JV, Cameron S, Rhodes T, Ahmed S, Bird S, Fox R, Renton A, Stimson GV, Goldberg D. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis. J Viral Hepat. 2005 Nov;12(6):655-62.
  • Taylor A, Hutchinson S, Lingappa J, Wadd S, Ahmed S, Gruer L, Taylor TH Jr, Roy K, Gilchrist G, McGuigan C, Penrice G, Goldberg D. Severe illness and death among injecting drug users in Scotland: a case-control study. Epidemiol Infect. 2005 Apr;133(2):193-204.
  • Hutchinson SJ, Wadd S, Taylor A, Bird SM, Mitchell A, Morrison DS, Ahmed S, Goldberg DJ. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine.2004 Nov 25;23(2):210-4.
  • Koffa MD, Clements JB, Izaurralde E, Wadd S, Wilson SA, Mattaj IW, Kuersten S. Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway. EMBO J. 2001 Oct 15;20(20):5769-78.
  • Bryant HE, Wadd S, Lamond AI, Silverstein SJ, Clements JB. Herpes simplex virus IE63 (ICP27) protein interacts with spliceosome-associated protein 145 and inhibits splicing prior to the first catalytic step. J Virol. 2001 May;75(9):4376-85.
  • Bryant HE, Matthews DA, Wadd S, Scott JE, Kean J, Graham S, Russell WC, Clements JB. Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32. J Virol. 2000 Dec;74(23):11322-8.
  • Bryant HE, Wadd S, Filhol O, Scott JE, Hsieh TY, Everett RD, Clements JB. (1999) The multifunctional herpes simplex virus IE63 protein interacts with heterogeneous ribonucleoprotein K and with casein kinase 2. J Biol Chem. Oct 8;274(41):28991-8.
  • Wadd S, Bryant H, Filhol O, Scott JE, Hsieh TY, Evererett RD, Clements JB.  The multifunctional herpes simplex virus (IE63) protein interacts with heterogenous ribonucleoprotein K and with casein kinase 2. J Biol Chem. 1999. 274(41), 28991-8.
Bedfordshire University

Apply» Faculties & Departments» Department of Applied Social Studies» Staff» Sarah Wadd